TFF Pharmaceuticals and Cleveland Clinic to Advance Multivalent Universal Influenza Vaccine Candidates into Preclinical Testing
Funded through the National Institute of Allergy and Infectious Diseases (NIAID), the purpose of the research collaboration between TFF Pharmaceuticals and Cleveland Clinic is to develop a ...
Children International Hosts Ecuadorian Students in Kansas City for Global Finals of ‘Destination Imagination’ Tournament
The Ecuadorian youths, all participants in Children International programs, have demonstrated great resilience and focus in overcoming harsh conditions and other ills to practice and collaborate for ...
Shah Capital Withdraws Proxy Campaign Against Re-Election of Directors at Novavax’s 2024 Annual Meeting
Welcomes Recent Announcement by Novavax of Licensing Agreement with SanofiStresses Significant Value Still Remains to Be Unlocked at Novavax ...
Aesthetic Medical International Holdings Group Ltd. Announces Receipt of Delisting Decision from the Nasdaq Hearings Panel
Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today announced that it has received a ...
ECARX Announces First Quarter 2024 Unaudited Financial Results
SHANGHAI, China, May 20, 2024 (GLOBE NEWSWIRE) -- ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility tech provider, today announced unaudited financial results for the ...
Kraig Biocraft Laboratories Prepares to Accelerate Production Launch following Spring Trials Success
"The amazing successes of the spring production trials demonstrate that we have unlocked the key to metric ton level spider silk production," said Founder and CEO, Kim Thompson. "Our team is ready.
Ocugen Announces CSO to Present on Modifier Gene Therapy at International Society for Cell & Gene Therapy 2024
The OCU400 Phase 3 liMeliGhT clinical trial is currently underway and on track to meet the Company’s 2026 BLA and MAA approval targets. OCU400 is the first gene therapy program to enter Phase 3 with a ...
ANI Pharmaceuticals Announces the Launch of Kionex® Suspension
ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Kionex ® (Sodium Polystyrene Sulfonate Suspension USP) for Oral or Rectal use. Kionex ® Suspension is the ...
New Campaign from The Trial for #ClinicalEquality – “Worth Less” –Spotlights the Cost of Clinical Inequality
This next phase of the Trial for #ClinicalEquality continues to shine a light on the damaging impact that the lack of diversity in clinical trials has and underscores that it’s a critical issue that ...
Edison issues review on BB Biotech (BION): A recovering sector with a healthy prognosis
Edison Investment Research Limited Edison issues review on BB Biotech (BION): A recovering sector with a healthy prognosis ...
Sol-Gel Reports First Quarter 2024 Financial Results and Provides Corporate Updates
Phase 3 clinical trial of SGT-610 for Gorlin Syndrome with the first patient screened, is ongoing. Sol-Gel and Beimei Pharma announced an Asset ...
Nicole Robinson Appointed President of DataPath Inc.
PETAH TIKVA, Israel, May 20, 2024 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services, ...